autologous cd3+ cells transduced anti-cd19

Italy

Drugs containing this active substance

  • TECARTUS

    It is a gene therapy used for the treatment of mantle cell lymphoma and B-cell acute lymphoblastic leukemia in adults, when other available therapies are not effective.

    Form: solution for infusion

    Active substance Dosage
    autologous cd3+ cells transduced anti-cd19 -

    ATC: L01XL06

    Manufacturer: KITE PHARMA EU B.V.